Advertisement

Topics

Latest "irbesartan amlodipine irbesartan Hypertension" News Stories

21:38 EDT 23rd April 2017 | BioPortfolio

Here are the most relevant search results for "irbesartan amlodipine irbesartan Hypertension" found in our extensive news archives from over 250 global news sources.

More Information about irbesartan amlodipine irbesartan Hypertension on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about irbesartan amlodipine irbesartan Hypertension for you to read. Along with our medical data and news we also list irbesartan amlodipine irbesartan Hypertension Clinical Trials, which are updated daily. BioPortfolio also has a large database of irbesartan amlodipine irbesartan Hypertension Companies for you to search.

Showing "irbesartan amlodipine irbesartan Hypertension" News Articles 1–25 of 1,000+

Extremely Relevant

Thiazide-type diuretics may reduce risk of hip, pelvic fractures in adults with hypertension

After nearly five years of follow-up, adults with hypertension who received chlorthalidone had a 21 percent lower risk of hip and pelvic fractures compared with those who received lisinopril or amlodipine, according to a post hoc analysis of a randomized trial.


Relevant

BRIEF-Alembic Pharmaceuticals receives ANDA approval for drug to treat hypertension

* Alembic Pharmaceuticals Limited receives ANDA approval for Telmisartan and Amlodipine tablets Source text: [Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 18, 2016, title " Alembic Pharmaceutical...

Human medicines European public assessment report (EPAR): Amlodipine / Valsartan Mylan , amlodipine / valsartan, Revision: 1, Authorised


Antihypertensive Drug "Micatrio® Combination Tablets"

Nippon Boehringer Ingelheim Co., Ltd. (Head Office: Tokyo; President and Representative Director: Yoshiaki Aono, hereafter “Nippon Boehringer Ingelheim”) and Astellas Pharma Inc. (Head Office: Tokyo; President and CEO: Yoshihiko Hatanaka, hereafter “Astellas”) announced today that the companies have newly launched “Micatrio® Combination Tablets,” a combina...

Dimerix key patent allowed in Japan for use of lead drug candidate in the treatment of kidney disease

MELBOURNE, Australia, 31 January 2017: Dimerix Limited (ASX: DXB), a clinical stage biotechnology company committed to discovering and developing new therapeutic treatments identified using its proprietary screening assay, today announced the Japanese Patent Office has allowed a key patent covering the use of its lead compound DMX-200 for the treatment of kidney disease. The allowed claims und...

Antihypertensive Therapeutics in AsiaPacific Markets to 2021 Increasing Prevalence of Hypertension Drives Market Growth despite Weak Pipeline Prices from USD $4995

Antihypertensive Therapeutics in AsiaPacific Markets to 2021 Increasing Prevalence of Hypertension Drives Market Growth despite Weak PipelineSummaryHypertension is a chronic medical condition characterized by elevated blood pressure in the arteries. It affected an estimated 517 million people in 2014, a figure that will grow at a Compound Annual Growth Rate CAGR of 1.2% to 561 million in 2021 in ...

Dimerix Completes Recruitment of Part A of its Phase 2 Trial of DMX-200 in Chronic Kidney Disease

MELBOURNE, Australia, 6 December 2016:  Dimerix Limited (ASX: DXB), a clinical-stage biotechnology company committed to discovering and developing new therapeutic treatments identified using its proprietary screening assay, today announced that it has completed recruitment of patients into Part A of its Phase 2 trial for DMX-200, an innovative new treatment chronic kidney disease that combi...

Short-term variability and nocturnal decline in ambulatory blood pressure in normotension, white-coat hypertension, masked hypertension and sustained hypertension: a population-based study of older individuals in Spain

Screen for Endocrine Hypertension, Endocrine Society Says

The Endocrine Society has issued a new statement on endocrine hypertension, providing guidance on screening for at least 15 hormonal disorders that present with hypertension. Medscape Medical News

Black, Hispanic adults may have poorer hypertension control than white patients

Black and Hispanic patients with hypertension had poorer control of their condition compared with white patients with hypertension, according to a cross-sectional study. The researchers found the differences in hypertension were more pronounced in younger and uninsured patients.

Hypertension: Hypertension in pregnancy: a risk factor for the whole family?

Hypertension in pregnancy is a known risk factor for increased cardiovascular risk for both the mother and her offspring. New findings suggest the offspring of normotensive pregnancies should also be considered at risk of high blood pressure if their mother has had hypertension in other pregnancies.

Dimerix Raises AU $2 million to Advance Clinical Program

Dimerix Limited (“Dimerix” or “the Company”) advises that it has received commitments for a placement to raise AU $2,000,000 (before costs) (Placement). 333,333,333 new shares will be issued to sophisticated and professional investors under the Placement at an issue price of AU $0.006 per share. Westar Capital Ltd acted as Lead Manager to the offer. The issue of shares...

Renal Denervation for Uncontrolled Hypertension

Is renal denervation an effective option for managing uncontrolled hypertension? Current Opinion in Nephrology and Hypertension

High prevalence, incidence of hypertension among rural Africans living with HIV

About 12 percent of people living with HIV in rural Tanzania have hypertension at the moment of HIV diagnosis. An additional 10 percent will develop hypertension during the first months of antiretroviral therapy. This represents an incidence 1.5 times higher than that found in Europe or the United States.

Genetic screening in arterial hypertension

Arterial hypertension is a complex condition influenced by multiple interrelated genetic and environmental factors. This Review examines our progress in unravelling the genetic determinants of hypertension, and the future use of genetic testing to personalize treatment and to improve the design of randomized controlled trials for the condition.

Can Echo/Doppler Accurately Estimate LVEDP in Pulmonary Hypertension Patients?

In patients with pulmonary hypertension evaluated in a specialty clinic, echo/Doppler estimation of left ventricular end-diastolic pressure is not reliable for the determination of pre- vs. post-capillary pulmonary hypertension.

Hypertension: Role of γδ T cells in the development of hypertension

Hypertension: Thrombin amplification loop in hypertension

Dimerix Receptor-HIT data presented by Takeda at British Pharmacological Society Annual meeting

MELBOURNE, Australia, 14th December 2016: Dimerix Limited (ASX: DXB), a clinical-stage biotechnology company committed to discovering and developing new therapeutic treatments identified using its proprietary screening assay, today announced that Dr Louise Dickson from Takeda Pharmaceutical Company Limited (Takeda: www.takeda.com) has presented work conducted using the Dimerix Receptor-HIT techn...

Yoga Called Good Medicine for High Blood Pressure

THURSDAY, Dec. 8, 2016 -- Yoga may help reduce blood pressure in people who are at risk for developing hypertension, a new study finds. "Patients with pre-hypertension [slightly elevated blood pressure] are likely to develop hypertension [high blood...

Increased dementia risk predominantly in diabetes mellitus rather than in hypertension or hyperlipidemia: a population-based cohort study

The pathophysiology of insulin resistance-induced hypertension and hyperlipidemia might entail differences in dementia risk in cases with hypertension and hyperlipidemia without prior diabetes mellitus (DM). T...

Immune cells identified as the culprit linking hypertension and dementia.

Hypertension is a leading risk factor for dementia, however, the mechanisms underlying its damaging effects on the brain are poorly understood.  Now, a study from researchers at Weill Cornell Medicine shows that high blood pressure transforms cells of the immune system into agents of cognitive decline.  The team state that they have successfully isolated the molecular pathways by which hypertens...

Are diuretic additives fit for uncontrolled hypertensive patients receiving telmisartan and amlodipine treatment?

The effects of missed doses of amlodipine and losartan on blood pressure in older hypertensive patients

Hypertension: Role of ARHGAP42 in hypertension


Quick Search
Advertisement
 

News Quicklinks